« Back
Home /
Crisdesalazine

Crisdesalazine

Item no.	MOLN-M16640-50mg
Manufacturer	Molnova
CASRN	927685-43-6
Amount	50 mg
Quantity options	100 mg 10 mg 1 g 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>98% (HPLC)
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Molecular Weight	325, 287
Brief description	Crisdesalazine (AAD-2004, AAD2004) is a derivative of aspirin that inhibits microsomal PGE(2) synthase-1 (mPGES-1) activity in response to both LPS-treated BV2 cell with IC50 of 230 nM and recombinant human mPGES-1 protein with IC50 of 249 nM in vitro.
Note	Research use only, not for human use.
Stability	≥ 2 years
Receptor	PGE synthase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

MOLN-M16640-50mg.pdf

MOLN-M16640-50mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Delivery expected until 12/16/2025

Compare

Add to wishlist

Get an offer

Request delivery time